SGCB and chronic thromboembolic pulmonary hypertension: Riociguat, a stimulator of soluble Guanylate Cyclase (sGC), is recommended for managing inoperable CTEPH and persistent/recurrent CTEPH after pulmonary endarterectomy (PEA), receiving IB recommendations (2, 72).